Abstract
(N Engl J Med. 2024;390:154–164) Pregnancy induces cardiovascular physiological changes and can sometimes lead to severe complications. Severe cardiac degeneration leading to clinical heart failure during pregnancy or in the early postpartum period defines peripartum cardiomyopathy (PPCM), but little is known about its causes. This condition occurs in ∼1 in 2000 births globally, with more common diagnoses in Haiti (1 in 300) and Nigeria (1 in 100), and less commonly in other areas. Peripartum cardiomyopathy is a leading cause of maternal death and is responsible for up to 60% of cases of peripartum cardiogenic shock. This article is a review of what is known about PPCM, its clinical presentation, pathogenesis, management, outcomes, and future directions for research.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
